HYDRASYS 2 SCAN FOCUSING is the “all-in-one” analyser for gel electrophoresis. The system offers analytical solutions for a high level of performance, matching clinical diagnostic requirements.
The analyser carries out electrophoresis steps, from sample application to final reading. It is a fast and easy to operate instrument, offering a comprehensive test menu of more than 60 HYDRAGEL programs.
HYDRASYS 2 SCAN FOCUSING when coupled with the ASSIST is designed to accomodate all workflow requirements; by automating sample preparation to ensure standardisation and traceability.
Have confidence when reporting your patients’ results with best-in-class gel electrophoresis assays.
Ability to migrate, stain, & scan gels on one system.
PHORESIS Core Software provides tools for interpretation, data & result management and networking.
Automation and standardization of samples preparation with ASSIST.
Sample types: Serum, urine, plasma CSF, whole blood
Throughput (tests/hour)
Proteinuria screening for renal disease.
Identification of monoclonal proteins by agarose gel electrophoresis.
Avoid interferences due to therapeutic Monoclonal Antibody with HYDRASHIFT Portfolio.
The high-resolution method for hemoglobin disorders screening.
Multimer assay simplified.
The gold standard assay for the alpha 1-antitrypsin (A1AT) phenotype testing.
The gold standard assay to objectively detect CNS local IgG synthesis in multiple sclerosis.
There are three types of von Willebrand Disease. In this leaflet, different cases from congenital and acquired VWD are presented.
IFCC Euromedlab 2021
Sebia booth: #121
Sebia Workshop: EduW22
Improve your lab performance by optimizing your Sebia solutions.
Understand your needs and constraints to provide you with the most suitable and integrated solution.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
IFCC Worldlab 2022
Sebia booth: #72
Sebia Workshop: EduW25
Educational Webinar with Juliana A. Silva
Educational Webinar with Dr. Rachel WHEELER
Educational Webinar Pr Simone Scarlata
Educational Webinar with Prof. Giovanni PALLADINI, PhD
IFCC Euromedlab /WorldLab 2023
Sebia booth: #21
Sebia Workshop: EduW15
Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.
European Myeloma Network Meeting – EMN 2024
Sebia booth: #9
The HYDRASHIFT portfolio include IVD test to mitigate interferences seen in immunofixation result for patient treated with isatuximab or daratumumab.
Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.
Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.
2017 Mc Donald Criteria for multiple sclerosis diagnosis includes CSF IgG oligoclonal bands.
2005 Multiple sclerosis consensus criteria includes CSF IgG oligoclonal bands.
Algorithm for congenital and acquired von Willebrand disease includes Hydragel vWF multimer analysis.
Multimer analysis to improve von Willebrand disease classification with Hydragel vWF multimer Sebia.
Correlation of von Willebrand factor with the severity of COVID-9 progression.
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.